These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9727076)

  • 1. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.
    Wizel B; Palmieri M; Mendoza C; Arana B; Sidney J; Sette A; Tarleton R
    J Clin Invest; 1998 Sep; 102(5):1062-71. PubMed ID: 9727076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8(+) T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients.
    Egui A; Thomas MC; Morell M; Marañón C; Carrilero B; Segovia M; Puerta CJ; Pinazo MJ; Rosas F; Gascón J; López MC
    Mol Immunol; 2012 Oct; 52(3-4):289-98. PubMed ID: 22750229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.
    Wizel B; Garg N; Tarleton RL
    Infect Immun; 1998 Nov; 66(11):5073-81. PubMed ID: 9784506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of HLA-A∗02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients.
    Marañón C; Egui A; Carrilero B; Thomas MC; Pinazo MJ; Gascón J; Segovia M; López MC
    Microbes Infect; 2011 Nov; 13(12-13):1025-32. PubMed ID: 21704723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B; Nunes M; Tarleton RL
    J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL.
    Low HP; Santos MA; Wizel B; Tarleton RL
    J Immunol; 1998 Feb; 160(4):1817-23. PubMed ID: 9469442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
    Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
    Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
    Buckner FS; Wipke BT; Van Voorhis WC
    Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
    Garg N; Tarleton RL
    Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
    Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
    J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes.
    Marañón C; Thomas MC; Planelles L; López MC
    Mol Immunol; 2001 Aug; 38(4):279-87. PubMed ID: 11566321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraflagellar rod protein-specific CD8+ cytotoxic T lymphocytes target Trypanosoma cruzi-infected host cells.
    Wrightsman RA; Luhrs KA; Fouts D; Manning JE
    Parasite Immunol; 2002 Aug; 24(8):401-12. PubMed ID: 12406194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.
    Fonseca SG; Moins-Teisserenc H; Clave E; Ianni B; Nunes VL; Mady C; Iwai LK; Sette A; Sidney J; Marin ML; Goldberg AC; Guilherme L; Charron D; Toubert A; Kalil J; Cunha-Neto E
    Microbes Infect; 2005 Apr; 7(4):688-97. PubMed ID: 15848276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
    Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K
    Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes.
    Wrightsman RA; Dawson BD; Fouts DL; Manning JE
    J Immunol; 1994 Oct; 153(7):3148-54. PubMed ID: 7522250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients.
    Garcia F; Sepulveda P; Liegeard P; Gregoire J; Hermann E; Lemonnier F; Langlade-Demoyen P; Hontebeyrie M; Lone YC
    Microbes Infect; 2003 Apr; 5(5):351-9. PubMed ID: 12737989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.
    Freire-de-Lima L; Alisson-Silva F; Carvalho ST; Takiya CM; Rodrigues MM; DosReis GA; Mendonça-Previato L; Previato JO; Todeschini AR
    J Biol Chem; 2010 Apr; 285(18):13388-96. PubMed ID: 20106975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.